End-Stage Renal Disease News

• When Should Those With End-Stage Kidney Disease Forego Dialysis? Australia and the UK have long had programs whereby some elderly patients with end-stage kidney disease, or those with many comorbidities, opt to forego dialysis, but the US has lagged behind.
  Medscape Medical News, May 23, 2022
• AUA 2022 AUA 2022: A Report From the Trenches Colorado urologist Henry M. Rosevear, MD, offers his take on the scientific highlights of this year's annual meeting of the American Urological Association.
  Medscape Medical News, May 19, 2022
• US Allows More Baby Formula Imports to Fight Shortage 'The FDA expects measures and steps it's taking with infant formula manufacturers will mean more and more supply is on the way or on store shelves moving forward,' said FDA commissioner Robert Califf.
  Associated Press, May 17, 2022
• Black Veterans Report Stress When Receiving Kidney Care New research suggests that racism in the hospital setting created emotional and physical stress for Black veterans with chronic kidney illness as well as a high level of skepticism toward medicine.
  Medscape Medical News, May 17, 2022
• Can Individualized Care for Kidney Disease in HIV Improve Outcomes? A need for dose adjustments and the possibility of drug-drug interactions have been identified in a study of advanced kidney disease in persons living with HIV.
  Medscape Medical News, May 09, 2022
• HBCU Medical Schools to Tackle Organ Transplant Disparities The collaboration follows a National Academies of Sciences, Engineering and Medicine report that found significant disparities in the nation's organ transplant system.
  Associated Press, May 05, 2022
• ACP-IM 2022 Bone, Breath, Heart, Guts: Eight Essential Papers in Primary Care At the 2022 ACP-IM meeting, editors from the Annals of Internal Medicine highlighted recent papers with key implications for internal medicine clinicians.
  Medscape Medical News, May 04, 2022
• Support for Prioritizing Kidney Transplant Patients for COVID Boosters Among kidney-transplant recipients, two doses of an mRNA SARS-CoV-2 vaccine will lower the risk for infection, although perhaps not as much compared with the general population, according to a study from the Czech Republic.
  Reuters Health Information, May 02, 2022
• 'Really Low' Risks for Living Kidney Donation, Says Surgeon Complications are typically incision-related and most occur after patients go home from the hospital, meaning close follow-up after discharge is needed.
  Medscape Medical News, April 28, 2022
• Doc's Condiment Crusade Helps Patients Kick Salt Habit New Orleans nephrologist Dr Adrian Baudy IV brews a no-salt hot sauce that packs a punch but is kind on the kidneys.
  Medscape Medical News, April 22, 2022
• End-Stage Kidney Disease Doubles: Treat Patients Earlier to Prevent It Patients with end-stage kidney disease doubled over the last 20 years, leading to calls for better management of conditions that cause it. An intervention among Native Americans has had some impact.
  Medscape Medical News, March 25, 2022
• ISN 2022 FDA Rejects Bardoxolone as First Alport Syndrome Agent Alport syndrome, a rare genetic disease that causes early kidney failure, continues to have no approved treatment, but advocates foresee progress in diagnosis and awareness from the failed approval attempt.
  Medscape Medical News, March 15, 2022
• Kidney Policy Increases Patient Referrals, Evaluations Implementation of the kidney allocation system led to increased patient referrals by dialysis centers and more evaluations by transplant centers. Fewer evaluated patients were waitlisted than before.
  Medscape Medical News, March 14, 2022
• Gene Testing for Kidney Disease Risk Prompts Behavior Change Test results for kidney failure risk prompt positive behavior change in patients and providers that might offset risk of developing chronic kidney disease and end-stage renal failure later in life.
  Medscape Medical News, March 09, 2022
• ISN 2022 Avacopan Shows Efficacy Signal for Rare Kidney Disease, C3G Avacopan, recently FDA approved for ANCA-associated vasculitis, showed significant benefit for reducing disease chronicity in a randomized trial of 52 patients with C3 glomerulopathy.
  Medscape Medical News, March 07, 2022
• Plasma Exchange Works for ANCA-Associated Vasculitis Plasma exchange can be an effective treatment for anti-neutrophil cytoplasm antibody-associated vasculitis, according to an updated systematic review and meta-analysis.
  Reuters Health Information, March 04, 2022
• ARBs and Cancer Risk: New Meta-Analysis Raises Questions Again The trial-level analysis suggests a dose-response relationship between exposure to angiotensin receptor blockers and the risk for cancer, reawakening previous questions on this issue.
  Medscape Medical News, March 02, 2022
• Higher BMI Increases Risk of Diabetic Kidney Disease Higher BMI was associated with increased risk of diabetic nephropathy and decreased eGFR, particularly in women, in new research.
  Medscape Medical News, February 28, 2022
• Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.
  Medscape Medical News, February 22, 2022
• No COVID Vax, No Transplant: Unfair or Good Medicine? COVID vaccinations — and some people's resistance to them — have turned what used to be routine preparation controversial.
  WebMD Health News, February 04, 2022